COVID-19 Plasma Collection

Completed · Not applicable

Conditions studied: COVID-19

In brief

Patients who are severely ill with COVID-19 may benefit from receiving plasma infusions from donors who have recovered from the disease and are proven to no longer be infected. Efforts to initiate the collection and infusion of these products to high risk patients have been initiated around the world and the FDA has recently provided information about how this could be accomplished. As the Jefferson Blood Donor Center already has processes to collect, test and process blood, investigators are planning to make efforts to collect plasma for this use should it be necessary. The purpose of this study is to describe the process for identifying and collecting convalescent plasma from donors previously infected with the virus. The research portion on top of this standard blood product collection will the process of identification of subjects and processes by which blood products are processed in this special population. This protocol does not involve the administration of blood products to patients with COVID-19 infection.

Key facts

Study ID

NCT04344015

Run by

Thomas Jefferson University

People needed

206

Starts

2020-04-13

Expected to finish

2020-06-02

Last updated by the study team

2021-05-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years and older
• Prior diagnosis of COVID-19 documented by a laboratory test approved by the FDA
• Either: Complete resolution of all COVID-related symptoms for 14-28 days at the time of blood donation AND negative repeated SARS-CoV-2 test OR Complete resolution of all COVID-related symptoms for > 28 days
• Male donors, never-pregnant female donors, or previously pregnant female donors negative for HLA antibodies
• Meet all criteria for volunteer blood donation per Jefferson Blood Donor Center and the FDA

You may not qualify if…

• Failure to pass standard volunteer blood donor screening criteria required by the Jefferson Blood Donor Center and the FDA
• Female donors with HLA antibodies (per FDA requirements for convalescent plasma donors)
• Inadequate venous access for phlebotomy
• Currently pregnant

Where it is running

• Thomas Jefferson University Hospital — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.